The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival and treatment patterns of patients with metastatic urothelial cancer in France: Results of a cohort study using the French National Healthcare database (SNDS).
 
Philippe Barthelemy
Honoraria - Astellas Pharma; AstraZeneca; Bayer; BMS; Gilead Sciences; IPSEN; Janssen-Cilag; Merck KGaA; MSD; Novartis; Pfizer
Consulting or Advisory Role - AAA/Endocyte/Novartis; Amgen; AstraZeneca; Bayer; BMS; Eisai; Gilead Sciences; ipsen; Janssen-Cilag; Merck KGaA; MSD Oncology; Pfizer
Research Funding - IPSEN (Inst)
Travel, Accommodations, Expenses - BMS; IPSEN; Janssen-Cilag; Merck/Pfizer; MSD; Pfizer
 
Mairead Kearney
No Relationships to Disclose
 
Laura Luciani
Employment - Merck Sante SAS
 
Benoit Van Hille
Employment - Merck Sante SAS
 
Laurent Paret
Employment - Merck Sante SAS
 
Reyhan Hasanova
Employment - Oracle France
 
Fayssoil Fouad
Employment - Oracle France
 
Vanessa Velasco
Employment - Oracle France
 
Isabelle Durand-Zaleski
Consulting or Advisory Role - Amgen; Boston Scientific; Bristol-Myers Squibb; Merck KGaA; Merck KGaA; MSD; Pfizer; Roche; Takeda
 
Constance Thibault
Honoraria - AAA/Endocyte/Novartis; Accord Healthcare; Astellas Pharma; AstraZeneca; Bayer; Bristol Myers Squibb; Gilead Sciences; Ipsen; Janssen Oncology; Merck; MSD Oncology; Novartis; Pfizer; Seagen
Consulting or Advisory Role - AAA/Endocyte/Novartis; AstraZeneca; Bristol-Meyers Squibb; Gilead Sciences; Ipsen; Janssen Oncology; Merck; MSD Oncology; Pfizer
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb/Medarex (Inst); Janssen Oncology (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Janssen Oncology; MSD Oncology; Pfizer